SCHEMBL368880

SCHEMBL368880

CCCCCCCC(CCCC)c1cccc(C(=O)O)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
CYSLTR2 Q9NS75 1/20 0.48
CYSLTR1 Q9Y271 1/20 0.48
SLC37A4 O43826 1/20 0.46
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
KAT8 Q9H7Z6 4/20 0.40
BID P55957 3/20 0.40
MCL1 Q07820 3/20 0.40
BCL2L1 Q07817 2/20 0.40
BAK1 Q16611 2/20 0.40
PPARA Q07869 2/20 0.40
MEN1 O00255 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453793 0.99 ALDH1A1 (0.50) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL9766367 0.96 ALDH1A1 (0.46) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL28349037 0.93 ALDH1A1 (0.44) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL7795743 0.92 ALDH1A1 (0.45) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL7792309 0.92 ALDH1A1 (0.45) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL342806 0.91 ALDH1A1 (0.46) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL906284 0.87 ALDH1A1 (0.56) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL5271572 0.86 SLC37A4 (0.54) ALDH1A1CYSLTR2CYSLTR1SLC37A4KDM4E
SCHEMBL9615354 0.86 ALDH1A1 (0.52) ALDH1A1SLC37A4KDM4EHPGDHSD17B10
SCHEMBL9504215 0.86 ALDH1A1 (0.52) ALDH1A1SLC37A4KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 493 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251121-B1 TOPICAL COMPOSITION DSM IP ASSETS BV (NL) 2025-10-01 EP claimed
EP-4547194-A1 COSMETIC FORMULATIONS COMPRISING STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS 11584022 Canada Inc. (CA) 2025-05-07 EP claimed
EP-3937896-B1 SUNSCREEN COMPOSITIONS COMPRISING BUTYL METHOXYDIBENZOYLMETHANE, TRIAZINE DERIVATIVES AND PHOTOSTABILIZER BASF SE (DE) 2025-01-15 EP claimed
US-20250000770-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING KETYL/ACETYL OF GLYCERIN COMPOUND L'OREAL (FR) 2025-01-02 US claimed
EP-3878519-B1 TOPICAL SUN PROTECTION COMPOSITION SOC DE RECHERCHE COSMETIQUE S A R L (LU) 2024-08-14 EP claimed
WO-2024003794-A1 COSMETIC FORMULATIONS COMPRISING STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS 11584022 CANADA INC. (CA) 2024-01-04 WO claimed
US-20220378674-A1 WATER-IN-OIL COSMETIC COMPOSITION WITH MAXIMIZED FEELING OF MOISTURE KOLMAR KOREA CO., LTD. (KR) 2022-12-01 US claimed
EP-2827835-B2 SUPERABSORBENT POLYMERS AND SILICONE ELASTOMER FOR USE IN SKIN CARE COMPOSITIONS PROCTER & GAMBLE (US) 2022-09-07 EP claimed
EP-4019001-A1 WATER-IN-OIL COSMETIC COMPOSITION WITH MAXIMIZED MOIST FEELING Kolmar Korea Co., Ltd. (KR) 2022-06-29 EP claimed
WO-2022092550-A1 WATER-IN-OIL COSMETIC COMPOSITION WITH MAXIMIZED MOIST FEELING 한국콜마 주식회사 2022-05-05 WO claimed
EP-2297040-B1 SUNSCREEN COMPOSITION EDGEWELL PERSONAL CARE BRANDS LLC (US) 2018-01-10 EP claimed
EP-2334283-B1 RESILIENT PERSONAL CARE COMPOSITION COMPRISING POLYALKYL ETHER CONTAINING SILOXANE ELASTOMERS PROCTER & GAMBLE (US) 2013-02-27 EP claimed
EP-1670429-A1 COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL PREPARATIONS OF LIPID/WAX MIXTURES CONTAINING GASES Beiersdorf AG (DE) 2006-06-21 EP claimed
WO-2005009404-A1 COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL PREPARATIONS OF LIPID/WAX MIXTURES CONTAINING GASES BEIERSDORF AG (DE) 2005-02-03 WO claimed
EP-1458332-A1 CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL Beiersdorf AG (DE) 2004-09-22 EP claimed
EP-1162942-B1 PHOTOSTABLE SUNSCREEN COMPOSITIONS SYMRISE GMBH & CO KG (DE) 2004-06-02 EP claimed
WO-2004024110-A1 COSMETIC PREPARATION BASED ON OIL-CONTAINING MICROEMULSIONS BEIERSDORF AG (DE) 2004-03-25 WO claimed
WO-2003051319-A1 CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL BEIERSDORF AG (DE) 2003-06-26 WO claimed
WO-2003034979-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS SOL-GEL TECHNOLOGIES LTD. (IL) 2003-05-01 WO claimed
US-20020064541-A1 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients SOL-GEL TECHNOLOGIES LTD. (IL) 2002-05-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000770-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING KETYL/ACETYL OF GLYCERIN COMPOUND GK, KAT8, KAT5 ALDH1A1 500/4885CYSLTR2 276/4885CYSLTR1 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.